| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | | | Heparin-Na 25'000 I.E./5 mL B.
Braun | 10 x 5 ml | 54.10 | 78.60 | k.A. | | Infusion solution: Heparinum Natricum 5000 UI | B. Braun Medical SA | B | FB | G |
| | | | | | Liquemin 20'000 I.E. / 48 ml | 5 | | | k.A. | | Infusion solution: Heparinum Natricum 417 UI/ml | Drossapharm AG | B | FB | G |
| | | IP | CI | | Liquemin 25'000 I.E. / 5 ml | 5 Durchstechflasche(n) | 16.12 | 34.90 | k.A. | | Infusion solution: Heparinum Natricum 5000 UI/ml | Drossapharm AG | B | FB | G |
| | | IP | | | Heparin Bichsel 100
I.E./ml | 10 1 ampoule(s) à 5 ml | | | k.A. | | Injection solution: Heparinum Natricum 100 UI/ml | Laboratorium Dr. G.
Bichsel AG | ● B | FB | G |
| | | IP | | | Heparin Sintetica 20`000
UI/48 ml | | | | k.A. | | soluzione per infusione: Heparinum Natricum 417 UI/ml | Sintetica SA | B | FB | G |
| | | IP | CI | | Heparin Bichsel 417
I.E./ml | 10 x 48 ml | | | k.A. | | Infusion solution: Heparinum Natricum 417 UI/ml | Laboratorium Dr. G.
Bichsel AG | B | FB | G |
| | | | | | Liquemin 20'000 I.E. / 48 ml | | | | k.A. | | Infusion solution: Heparinum Natricum 417 UI/ml | Drossapharm AG | B | FB | G |
| | | IP | CI | | Heparin Bichsel 1000
I.E./ml | 10 x 20 ml | | | k.A. | | Injection solution: Heparinum Natricum 1000 UI/ml | Laboratorium Dr. G.
Bichsel AG | B | FB | G |
| | | IP | CI | | Heparin Bichsel 5000
I.E./ml | 10 x 5 ml | | | k.A. | | Injection solution: Heparinum Natricum 5000 UI/ml | Laboratorium Dr. G.
Bichsel AG | B | FB | G |
| | | IP | CI | | Heparin Bichsel 5000
I.E./ml | 10 x 20 ml | | | k.A. | | Injection solution: Heparinum Natricum 5000 UI/ml | Laboratorium Dr. G.
Bichsel AG | B | FB | G |
|
| | | IP | | V/S | Kybernin P 500 | 500 IE | | | k.A. | | | CSL Behring AG | B | FB | G |
| | | IP | | V/S | Kybernin P 1000 | 1000 IE | | | k.A. | | | CSL Behring AG | B | FB | G |
| | | IP | | V/S | Atenativ 500 I.E. | 500 IE | | | k.A. | | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung: Antithrombinum Iii Humanum 500 UI | Octapharma AG | B | FB | G |
| | | IP | | V/S | Atenativ 1000 I.E. | 1000 IE | | | k.A. | | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung: Antithrombinum Iii Humanum 1000 UI | Octapharma AG | B | FB | G |
|
| | | IP | CI | | Fragmin 10'000 I.E./4 mL | 10 x 4 ml | 53.86 | 75.00 | 10 % | | Injection solution: Dalteparinum Natricum 2500 UI/ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 2'500 I.E./0.2 mL | 2 x 0.2 ml | 5.86 | 15.60 | 10 % | | Injection solution: Dalteparinum Natricum 2500U.I. / 0.2ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 2'500 I.E./0.2 mL | 10 x 0.2 ml | 26.83 | 45.60 | 10 % | | Injection solution: Dalteparinum Natricum 2500U.I. / 0.2ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 5'000 I.E./0.2 mL | 2 x 0.2 ml | 7.67 | 17.60 | 10 % | | Injection solution: Dalteparinum Natricum 5000U.I. / 0.2ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 5'000 I.E./0.2 mL | 10 x 0.2 ml | 37.54 | 57.25 | 10 % | | Injection solution: Dalteparinum Natricum 5000U.I. / 0.2ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 10'000 I.E./0,4 mL | 5 x 0.4 ml | 29.47 | 48.45 | 10 % | | Injection solution: Dalteparinum Natricum 10000U.I. / 0.4ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 12'500 I.E./0,5 mL | 5 x 0.5 ml | 37.58 | 57.30 | 10 % | | Injection solution: Dalteparinum Natricum 12500U.I. / 0.5ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 7'500 I.E./0,3 mL | 10 x 0.3 ml | 55.18 | 76.45 | 10 % | | Injection solution: Dalteparinum Natricum 7500U.I. / 0.3ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 15'000 I.E./0,6 mL | 5 x 0.6 ml | 43.02 | 63.20 | 10 % | | Injection solution: Dalteparinum Natricum 15000U.I. / 0.6ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 18'000 I.E./0,72 mL | 5 x 0.72 ml | 48.13 | 68.75 | 10 % | | Injection solution: Dalteparinum Natricum 18000U.I. / 0.72ml | Pfizer AG | B / SL | FB | G |
| | | IP | CI | | Fragmin 100'000 I.E./4 mL | 4 ml | 50.50 | 71.35 | 10 % | | Injection solution: Dalteparinum Natricum 100000U.I. / 4ml | Pfizer AG | B / SL | FB | G |
|
| | | IP | CI | | Clexane 20 mg/0.2 ml | 10 x 0.2 ml | 17.69 | 35.50 | 10 % | | Injection solution: Enoxaparinum Natricum 20 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| L | | IP | CI | | Clexane 20 mg/0.2 ml | 50 x 0.2 ml | 88.49 | 111.85 | 10 % | | Injection solution: Enoxaparinum Natricum 20 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane 40 mg/0.4 ml | 2 x 0.4 ml | 6.15 | 15.90 | 10 % | | Injection solution: Enoxaparinum Natricum 40 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane 40 mg/0.4 ml | 10 x 0.4 ml | 30.94 | 49.90 | 10 % | | Injection solution: Enoxaparinum Natricum 40 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| L | | IP | CI | | Clexane 40 mg/0.4 ml | 50 x 0.4 ml | 154.67 | 183.75 | 10 % | | Injection solution: Enoxaparinum Natricum 40 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane 60 mg/0.6 ml | 10 x 0.6 ml | 40.40 | 60.15 | 10 % | | Injection solution: Enoxaparinum Natricum 60 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane 80 mg/0.8 ml | 10 x 0.8 ml | 57.70 | 78.85 | 10 % | | Injection solution: Enoxaparinum Natricum 80 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane 100 mg/ml | 10 x 1 ml | 72.10 | 94.45 | 10 % | | Injection solution: Enoxaparinum Natricum 100 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane 120 mg/0.8 ml | 2 x 0.8 ml | 17.08 | 35.00 | 10 % | | Injection solution: Enoxaparinum Natricum 120 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane 120 mg/0.8 ml | 10 x 0.8 ml | 79.58 | 102.50 | 10 % | | Injection solution: Enoxaparinum Natricum 120 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane 150 mg/ml | 2 x 1 ml | 20.89 | 39.15 | 10 % | | Injection solution: Enoxaparinum Natricum 150 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane 150 mg/ml | 10 x 1 ml | 97.35 | 121.75 | 10 % | | Injection solution: Enoxaparinum Natricum 150 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Clexane multi | Durchstechflasche(n) | 21.69 | 39.70 | 10 % | | Injection solution: Enoxaparinum Natricum 300 mg | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Inhixa 2000 IE (20 mg) | 10 | 15.04 | 32.75 | 10 % | | Injection solution: Enoxaparinum Natricum 20 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| L | | IP | CI | | Inhixa 2000 IE (20 mg) | 50 | 75.21 | 98.20 | 10 % | | Injection solution: Enoxaparinum Natricum 20 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| | | IP | CI | | Inhixa 4000 IE (40 mg) | 2 | 5.60 | 15.30 | 10 % | | Injection solution: Enoxaparinum Natricum 40 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| | | IP | CI | | Inhixa 4000 IE (40 mg) | 10 | 28.14 | 47.00 | 10 % | | Injection solution: Enoxaparinum Natricum 40 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| L | | IP | CI | | Inhixa 4000 IE (40 mg) | 50 | 140.69 | 169.40 | 10 % | | Injection solution: Enoxaparinum Natricum 40 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| | | IP | CI | | Inhixa 6000 IE (60 mg) | 10 | 36.74 | 56.35 | 10 % | | Injection solution: Enoxaparinum Natricum 60 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| | | IP | CI | | Inhixa 8000 IE (80 mg) | 10 | 52.47 | 73.50 | 10 % | | Injection solution: Enoxaparinum Natricum 80 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| | | IP | CI | | Inhixa 10000 IE (100 mg) | 10 | 65.56 | 87.70 | 10 % | | Injection solution: Enoxaparinum Natricum 100 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| | | IP | CI | | Inhixa 12000 IE (120 mg) | 10 | 72.36 | 95.10 | 10 % | | Injection solution: Enoxaparinum Natricum 120 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| | | IP | CI | | Inhixa 15000 IE (150 mg) | 10 | 88.52 | 112.70 | 10 % | | Injection solution: Enoxaparinum Natricum 150 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| | | IP | | | Inhixa Multi 30000 IE
(300 mg) | | 16.59 | 34.45 | 10 % | | Injection solution: Enoxaparinum Natricum 300 mg | Viatris Pharma GmbH | B / SL / SG | FB | G |
| | | IP | CI | | Hepaxane 2000 IE/UI (20
mg)/0.2 ml | 10 | 15.04 | 32.75 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 20 mg | Effik SA | B / SL / SG | FB | G |
| L | | IP | CI | | Hepaxane 2000 IE/UI (20
mg)/0.2 ml | 50 | 75.22 | 98.20 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 20 mg | Effik SA | B / SL / SG | FB | G |
| | | IP | CI | | Hepaxane 4000 IE/UI (40
mg)/0.4 ml | 2 | 5.60 | 15.30 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg | Effik SA | B / SL / SG | FB | G |
| | | IP | CI | | Hepaxane 4000 IE/UI (40
mg)/0.4 ml | 10 | 28.14 | 47.00 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg | Effik SA | B / SL / SG | FB | G |
| L | | IP | CI | | Hepaxane 4000 IE/UI (40
mg)/0.4 ml | 50 | 140.69 | 169.40 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg | Effik SA | B / SL / SG | FB | G |
| | | IP | CI | | Hepaxane 6000 IE/UI (60
mg)/0.6 ml | 10 | 36.79 | 56.45 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 60 mg | Effik SA | B / SL / SG | FB | G |
| | | IP | CI | | Hepaxane 8000 IE/UI (80
mg)/0.8 ml | 10 | 52.47 | 73.50 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 80 mg | Effik SA | B / SL / SG | FB | G |
| | | IP | CI | | Hepaxane 10'000 IE/UI
(100 mg)/1 ml | 10 | 65.57 | 87.75 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 100 mg | Effik SA | B / SL / SG | FB | G |
| | | IP | CI | | Hepaxane 12'000 IE/UI
(120 mg)/0.8 ml | 10 | 72.38 | 95.15 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 120 mg | Effik SA | B / SL / SG | FB | G |
| | | IP | CI | | Hepaxane 15'000 IE/UI
(150 mg)/1 ml | 10 | 88.51 | 112.70 | 10 % | | solution injectable en seringue préremplie: Enoxaparinum Natricum 150 mg | Effik SA | B / SL / SG | FB | G |
| | | IP | CI | | Hepaxane 2000 IE/UI (20
mg)/0.2 ml | 20 | | | k.A. | | solution injectable en seringue préremplie: Enoxaparinum Natricum 20 mg | Effik SA | B | FB | G |
| | | IP | CI | | Hepaxane 4000 IE/UI (40
mg)/0.4 ml | 6 | | | k.A. | | solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg | Effik SA | B | FB | G |
| | | IP | CI | | Hepaxane 4000 IE/UI (40
mg)/0.4 ml | 20 | | | k.A. | | solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg | Effik SA | B | FB | G |
| | | IP | CI | | Hepaxane 6000 IE/UI (60
mg)/0.6 ml | 20 | | | k.A. | | solution injectable en seringue préremplie: Enoxaparinum Natricum 60 mg | Effik SA | B | FB | G |
| | | IP | CI | | Clexane 60 mg/0.6 ml | 2 x 0.6 ml | | | k.A. | | Injection solution: Enoxaparinum Natricum 60 mg | Sanofi-Aventis
(Suisse) SA | B | FB | G |
| | | IP | CI | | Clexane 60 mg/0.6 ml | 50 x 0.6 ml | | | k.A. | | Injection solution: Enoxaparinum Natricum 60 mg | Sanofi-Aventis
(Suisse) SA | B | FB | G |
| | | IP | CI | | Clexane 80 mg/0.8 ml | 2 x 0.8 ml | | | k.A. | | Injection solution: Enoxaparinum Natricum 80 mg | Sanofi-Aventis
(Suisse) SA | B | FB | G |
| | | IP | CI | | Clexane 80 mg/0.8 ml | 50 x 0.8 ml | | | k.A. | | Injection solution: Enoxaparinum Natricum 80 mg | Sanofi-Aventis
(Suisse) SA | B | FB | G |
| | | IP | CI | | Clexane 100 mg/ml | 2 x 1 ml | | | k.A. | | Injection solution: Enoxaparinum Natricum 100 mg | Sanofi-Aventis
(Suisse) SA | B | FB | G |
| | | IP | CI | | Clexane 100 mg/ml | 50 x 1 ml | | | k.A. | | Injection solution: Enoxaparinum Natricum 100 mg | Sanofi-Aventis
(Suisse) SA | B | FB | G |
| | | IP | CI | | Clexane 120 mg/0.8 ml | 50 x 0.8 ml | | | k.A. | | Injection solution: Enoxaparinum Natricum 120 mg | Sanofi-Aventis
(Suisse) SA | B | FB | G |
| | | IP | CI | | Clexane 150 mg/ml | 50 x 1 ml | | | k.A. | | Injection solution: Enoxaparinum Natricum 150 mg | Sanofi-Aventis
(Suisse) SA | B | FB | G |
| | | IP | CI | | Inhixa 2000 IE (20 mg) | 2 | | | k.A. | | Injection solution: Enoxaparinum Natricum 20 mg | Viatris Pharma GmbH | B | FB | G |
| | | IP | CI | | Inhixa 6000 IE (60 mg) | 2 | | | k.A. | | Injection solution: Enoxaparinum Natricum 60 mg | Viatris Pharma GmbH | B | FB | G |
| | | IP | CI | | Inhixa 6000 IE (60 mg) | 50 | | | k.A. | | Injection solution: Enoxaparinum Natricum 60 mg | Viatris Pharma GmbH | B | FB | G |
| | | IP | CI | | Inhixa 8000 IE (80 mg) | 2 | | | k.A. | | Injection solution: Enoxaparinum Natricum 80 mg | Viatris Pharma GmbH | B | FB | G |
| | | IP | CI | | Inhixa 8000 IE (80 mg) | 50 | | | k.A. | | Injection solution: Enoxaparinum Natricum 80 mg | Viatris Pharma GmbH | B | FB | G |
| | | IP | CI | | Inhixa 10000 IE (100 mg) | 2 | | | k.A. | | Injection solution: Enoxaparinum Natricum 100 mg | Viatris Pharma GmbH | B | FB | G |
| | | IP | CI | | Inhixa 10000 IE (100 mg) | 50 | | | k.A. | | Injection solution: Enoxaparinum Natricum 100 mg | Viatris Pharma GmbH | B | FB | G |
| | | IP | CI | | Inhixa 12000 IE (120 mg) | 2 | | | k.A. | | Injection solution: Enoxaparinum Natricum 120 mg | Viatris Pharma GmbH | B | FB | G |
| | | IP | CI | | Inhixa 15000 IE (150 mg) | 2 | | | k.A. | | Injection solution: Enoxaparinum Natricum 150 mg | Viatris Pharma GmbH | B | FB | G |
|
| | | IP | | | Fraxiforte 0.8 mL | 2 syringe(s) | 26.62 | 45.35 | 10 % | | Injection solution: Nadroparinum Calcicum 134 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiforte 0.8 mL | 10 syringe(s) | 133.08 | 161.15 | 10 % | | Injection solution: Nadroparinum Calcicum 134 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiforte 1 mL | 2 syringe(s) | 32.62 | 51.90 | 10 % | | Injection solution: Nadroparinum Calcicum 166 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiforte 1 mL | 10 syringe(s) | 162.30 | 192.95 | 10 % | | Injection solution: Nadroparinum Calcicum 166 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiparine 0,2 mL | 10 syringe(s) | 18.29 | 36.30 | 10 % | | Injection solution: Nadroparinum Calcicum 17 mg | Viatris Pharma GmbH | ● B / SL | FB | G |
| | | IP | | | Fraxiparine 0,3 mL | 2 syringe(s) | 6.37 | 16.15 | 10 % | | Injection solution: Nadroparinum Calcicum 25 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiparine 0,3 mL | 10 syringe(s) | 33.39 | 52.75 | 10 % | | Injection solution: Nadroparinum Calcicum 25 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiparine 0,4 mL | 10 syringe(s) | 31.96 | 51.15 | 10 % | | Injection solution: Nadroparinum Calcicum 33 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiparine 0,6 mL | 10 syringe(s) | 38.94 | 58.75 | 10 % | | Injection solution: Nadroparinum Calcicum 50 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiparine 0,8 mL | 10 syringe(s) | 69.28 | 91.75 | 10 % | | Injection solution: Nadroparinum Calcicum 67 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiparine 1 mL | 10 syringe(s) | 91.90 | 116.35 | 10 % | | Injection solution: Nadroparinum Calcicum 83 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiforte 0.6 mL | 2 syringe(s) | 20.22 | 38.40 | 10 % | | Injection solution in prefilled syringe: Nadroparinum Calcicum 100 mg | Viatris Pharma GmbH | B / SL | FB | G |
| | | IP | | | Fraxiforte 0.6 mL | 10 syringe(s) | 101.09 | 126.35 | 10 % | | Injection solution in prefilled syringe: Nadroparinum Calcicum 100 mg | Viatris Pharma GmbH | B / SL | FB | G |
|
| | | IP | | | Orgaran | 10 ampoule(s) | | | k.A. | | Injection solution: Danaparoidum Natricum 750U. / 0.6ml | Viatris Pharma GmbH | B | FB | G |
